Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2016-01-18
2020-02-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients
NCT02219750
Improving Glycemic Control in DM2 Patients in the Ambulatory Setting
NCT04800471
Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia
NCT03179280
A Comparison of Two Initial Dosing Formulas
NCT01377155
Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes
NCT04739241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premixed Insulin
Premixed Human Insulin
Premixed Human Isophane Insulin Suspension + Human Insulin Injection
premixed human insulin
Premixed Insulin
Premixed Insulin Analog Biphasic Aspart 30
Premixed insulin
Premixed Insulin Analog
Premixed Human Isophane Insulin Suspension + Human Insulin Injection
premixed human insulin
Premixed Insulin
Premixed Insulin Analog Biphasic Aspart 30
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Premixed Human Isophane Insulin Suspension + Human Insulin Injection
premixed human insulin
Premixed Insulin
Premixed Insulin Analog Biphasic Aspart 30
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients were on Premixed Human Insulin 30/70 twice daily with or without metformin
* baseline HbA1c\<7%
Exclusion Criteria
* stage 4 Chronic Kidney Disease
* use of antidiabetic medications other than insulin and metformin
* major cardiovascular event during the last six months
* acute illness and hospitalization during the last two weeks
* pregnancy
* absence of good metabolic control assessed with self-monitoring of blood glucose during the week before entering the study (\>20% of the measurements \<80mg/dl or \>130mg/dl)
* inability of the patients to understand the study procedures and sign the consent form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Triantafyllos Didangelos
Associate Professor of Internal Medicine-Diabetology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Triantafyllos Didangelos, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
AHEPA Hospital Aristotle University Of Thessaloniki
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2279
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.